Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY – Get Free Report) saw a significant decline in short interest in August. As of August 31st, there was short interest totaling 7,738 shares, a decline of 94.2% from the August 15th total of 134,297 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 68,415 shares, the days-to-cover ratio is currently 0.1 days.
Analyst Upgrades and Downgrades
Separately, Zacks Research lowered Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research note on Wednesday, July 22nd. Two research analysts have rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.
Get Our Latest Report on SKHHY
Sonic Healthcare Stock Performance
About Sonic Healthcare
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
Further Reading
- Five stocks we like better than Sonic Healthcare
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
